Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Fennec Pharmaceuticals Inc.(FENC) | 195,700 | 195,700 | 0 | $1.19M | $1.62M | 11.03% | +$432.5K |
| Ardelyx Inc | 335,400 | 335,400 | 0 | $1.65M | $1.31M | 8.93% | -$332.0K |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 45,900 | 45,900 | 0 | $1.02M | $1.27M | 8.62% | +$250.6K |
| BridgeBio Pharma, Inc.(BBIO) | 26,000 | 26,000 | 0 | $898.8K | $1.12M | 7.62% | +$223.9K |
| Insmed Incorporated(INSM) | 30,500 | 10,650 | -19,850 | $2.33M | $1.07M | 7.28% | -$1.26M |
| Mineralys Therapeutics, Inc.(MLYS) | 79,000 | 79,000 | 0 | $1.25M | $1.07M | 7.26% | -$185.7K |
| Milestone Pharmaceuticals Inc.(MIST) | 548,806 | 548,806 | 0 | $439.1K | $1.06M | 7.23% | +$625.6K |
| Avadel Pharmaceuticals Plc | 98,700 | 98,700 | 0 | $772.8K | $873.5K | 5.93% | +$100.7K |
| Jasper Therapeutics, Inc.(JSPR) | 146,500 | 146,500 | 0 | $630.0K | $813.1K | 5.52% | +$183.1K |
| Benitec Biopharma Inc.(BNTC) | 62,000 | 62,000 | 0 | $806.6K | $725.4K | 4.93% | -$81.2K |
| Geron Corporation(GERN) | 500,000 | 500,000 | 0 | $795.0K | $705.0K | 4.79% | -$90.0K |
| Arcutis Biotherapeutics, Inc.(ARQT) | 46,300 | 46,300 | 0 | $724.1K | $649.1K | 4.41% | -$75.0K |
| Disc Medicine, Inc.(IRON) | 10,600 | 10,600 | 0 | $526.2K | $561.4K | 3.81% | +$35.2K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 55,000 | 55,000 | 0 | $675.7K | $515.1K | 3.50% | -$160.6K |
| REGENXBIO Inc.(RGNX) | 57,750 | 57,750 | 0 | $412.9K | $474.1K | 3.22% | +$61.2K |
| Biohaven Ltd.(BHVN) | 22,700 | 22,700 | 0 | $545.7K | $320.3K | 2.17% | -$225.4K |
| Mersana Therapeutics Inc | 644,000 | 644,000 | 0 | $221.7K | $190.6K | 1.29% | -$31.0K |
| Seres Therapeutics, Inc.(MCRB) | 0 | 17,038 | +17,038 | $0 | $189.3K | 1.29% | +$189.3K |
| Humacyte, Inc.(HUMA) | 83,500 | 83,500 | 0 | $142.4K | $174.5K | 1.18% | +$32.1K |
| Bluebird Bio Inc | 78,912 | 0 | -78,912 | $385.1K | $0 | — | -$385.1K |
| Seres Therapeutics, Inc.(MCRB) | 340,761 | 0 | -340,761 | $238.5K | $0 | — | -$238.5K |
| Spruce Biosciences Inc | 75,000 | 0 | -75,000 | $21.8K | $0 | — | -$21.8K |